In Luminal B tumor, the pCR rate in ≤40-year-old patients was higher than that in >40-year-old patients, while in the HR-/HER2+ subtype, the >40-year-old group was more likely to achieve pCR (P < 0.05). This evidence concerns the gene ERBB2 and neoplasm.